在接受腹腔透析的患者中使用empagliflozin和超过量
Yohei Doi1,2, Maki Shinzawa1,3, Tetsuya Arisato4
1Department of Nephrology, Graduate School of Medicine, The University of Osaka, Suita, Osaka, Japan.
Kidney international reports
|January 16, 2026
概括
在接受腹腔透析 (PD) 的患者中,empagliflozin没有显著增加超过量 (UFV). 这项研究表明,SGLT2抑制剂在增强PD液体去除方面具有有限的短期临床效用.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
- 代谢疾病 代谢疾病
背景情况:
- -葡萄糖共运输体2 (SGLT2) 在人体腹膜中存在.
- 临床前数据表明,SGLT2抑制剂可以通过降低葡萄糖吸收来改善腹膜透析 (PD) 中的超过 (UFV).
研究的目的:
- 评估empagliflozin是否会增加PD患者的UFV.
- 评估SGLT2抑制剂在PD中的短期临床效用.
主要方法:
- 一个多中心,随机,双盲,安慰剂控制的交叉试验.
- 患者接受了empagliflozin (10 mg/d) 或安慰剂8周,有4周的洗期.
- 主要结局:每日UFV从基线到第8周的变化.
主要成果:
- 与安慰剂相比,empagliflozin没有显著改变每日UFV (中位数差异-38毫升;P=0.36).
- 没有观察到对透析葡萄糖或度的显著影响.
- 尿液中的葡萄糖分泌量显著增加,但尿液体积和蛋白质分泌量保持不变.
结论:
- 恩帕格利弗洛辛没有证明在改善UFV的短期内对PD患者有显著的益处.
- 这些发现表明empagliflozin在增强PD中超的临床实用性有限.
相关概念视频
Peritoneal Dialysis I: Introduction and Procedure
2.4K
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
2.4K
Acute Kidney Injury V: Interprofessional Care
297
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
297
Peritoneal Dialysis III: Nursing Management
676
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
676
Renal Drug Excretion: Glomerular Filtration
1.2K
The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production occurs. A nephron has two main components: a renal corpuscle and a renal tubule.
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....
1.2K
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
557
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
557
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
406
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
406


